突触后细胞骨架与乙酰胆碱受体簇

乙酰胆碱受体(AChR)簇的形成在神经肌接头的生长过程中是非常关键的一步。突触后细胞骨架参与AChR簇的形成。     

人体小卫星DNA探针的制备

根据人体小卫星DNA核心顺序,化学合成长23碱基寡核苷酸探针,筛选人体基因组文库,旨在获得能用作遗传分析探针的小卫星顺序。结果得到15个含小卫星的阳性重组子。随机取其一(C_(35.9))作探针,试做群体分析。所有个体均可检出多条杂交带。其中某些带具有多态性。在一定检测条件下,检出的DNA图谱在有限的个体内具有个体特异性。结果表明筛选文库得到的小卫星顺序可用于小卫星多态性的检测。其它小卫星探针的筛选和应用性研究正在进行。     

中国的红树林

我国红树林主要分布在热带及亚热带沿海盐滩和河川出口的冲积盐性土上,包括24个科,47种,属于东方群系。从广西钦州湾开始经北海港,沿雷州半岛的海安分为两支,一支往南经海南岛的儋县新英港,向东经琼山县的东寨港和文昌县的清澜港,沿着东海岸至崖县的三亚港,又折向北到达东方县的八所港;另一支向东北经湛江的赤坎,阳江的海陵岛,台山的上下川岛,中山的三灶岛,新会的崖门,再沿海岸往北至福建的福鼎和台湾的新竹港。根据我国红树林的主要构成种类、外貌、生境,大致可分为3大群系和10个群落。(1) 矮灌木群系——这个群系多见于纬度稍高的海滩前缘,包括海榄雌群落和桐花树群落。这些群落在演替上处于前期阶段。(2) 高大稠密灌木群系——这个群系由于气温、年降雨量的差异和土壤性质的不同,组成这个群系的种类也有不同,不过都是以红树族的种类为建群种,它包括4个群落:红树群落、红海兰群落和角果木群落,这些群落在演替上属于中期阶段。(3) 乔木群系——这个群系主要分布在海南岛东北和东部海岸,所在地一般地势较高,前缘地带每日潮涨仍有海水浸淹。后缘地带只有每月大潮时才有海水到达,土壤比较固结,它包括木榄群落、海莲和尖瓣海莲群落、海桑群落及半红树林水椰群落。这些群落在演替上是处于后期阶段。组成我国红树林的种类大多数都具有较高的经济价值,如角果木是优质单宁的原料,有些种类经过发酵处理成为高营养的饲料和肥料。此外,沿海浮游生物的产量有红树林比无红树林的地带高达7倍,因此加强对红树林的经营和保护应采取积极态度和有效措施。     

电离辐射后大鼠离体胰腺腺泡淀粉酶释放及M受体数量变化

我们曾观察到大鼠经γ-射线照射后胰淀粉酶活性降低和分泌减少[1],为进一步探讨照射后胰酶分泌减少的机制,本研究制备出分散的大鼠胰腺腺泡悬液并以不同浓度的~3H-二苯羟乙酸-3-喹咛环酯(~3Hquinuclidinyll benzilatc,简称~3H-QNB)进行M受体结合测定,同时观察胆碱能介质氨甲酰胆碱刺激腺泡所引起的淀粉酶释放反应。结果表明,γ-射线10Gy照射后3天,大鼠分散的胰腺腺泡在氨甲酰胆碱刺激时淀粉酶释放量减少到对照的50％,腺泡M受体与~3H-QNB最大结合量(Bmax)减少到对照的38％,伋M受体与~3H-QNB结合的解离常数(K_D)无改变,说明胰腺腺泡细胞M受体数量的减少可能是照射后胰腺腺泡分泌淀粉酶减少的原因之一。     

松辽盆地阿尔必期微体浮游植物新属种

该文描述了松辽盆地中白垩世阿尔必期泉头组三段的微体浮游植物化石1新属7新种,隶属于微咸水沟鞭藻类2属5新种(含4新亚种),淡水绿藻1属1种和疑源类1新属1新种。并对沟鞭藻 Ngktericysta Bint,1986进行了修订。     

Catalytic properties of chloroplast F1-ATPase modified at catalytic or noncatalytic sites by 2-azido adenine nucleotides

When heat-activated F1-ATPase from chloroplasts was repeatedly exposed to Mg2+ and 2-azido-ATP, followed by separation from medium nucleotides and photolysis, a total of two sites per enzyme, both catalytic and noncatalytic, were labeled. In a coupled assay with pyruvate kinase about half the activity was lost when one site per enzyme was modified. However, increased modification resulted in no further loss of activity. In contrast, methanol-sulfite activation of the enzyme showed a loss of most of the catalytic capacity when one site per enzyme was modified. Predominant labeling of either one catalytic or one noncatalytic site caused a loss of most of the activity in either assay. An indication that the enzyme modified at one site retained some catalytic activity was verified by measurement of the [18O]Pi species formed when [gamma-18O]ATP was hydrolyzed by partially derivatized enzyme. With either catalytic or noncatalytic site modification, the distributions of [18O]Pi species formed showed that the modified enzyme had different catalytic characteristics. An interpretation is that with modification by azido nucleotides at either catalytic or noncatalytic sites, capacity for rapid catalysis is largely lost but the remaining sites retain weak modified catalytic properties.     

Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines

Dimethylbenz[a]anthracene (DMBA)-induced transplantable fibrosarcomas in B2 homozygous chickens (SC line) grow progressively in normal chickens, but are rejected by chickens immunized previously with irradiated tumor cells and Corynebacterium parvum. Tumor-immune chickens resist challenge by the immunizing tumor lines as well as by some, but not all, fibrosarcoma lines. The pattern of cross-reactivity between four DMBA-induced transplantable tumor lines was examined in detail. Ability to reject a tumor challenge correlated very well (p less than 0.001) with the presence of delayed-type hypersensitivity (DTH) to that tumor. Immunization with one of two of the DMBA-induced lines tested also caused rejection of transplantable tumors developed from methylcholanthrene-induced and benzo(a)pyrene-induced primary fibrosarcomas. Although immunization with tumor caused DTH to chicken embryo fibroblasts (CEF), immunization with CEF failed to cause protective immunity or DTH to tumors. Presence of protective immunity, where tested, also correlated with the ability of spleen cells from immune donors to inhibit tumor growth in Winn tests. Humoral immunity exhibited even greater cross-reactivity than did cellular immunity. Distinct patterns of cross-reactivity were nevertheless observed with respect to the serum antibodies as detected in ELISA. Two of these patterns were also observed in several sera from primary tumor-bearing chickens, both including reactivity with CEF. Such reactivity was absent from normal chicken sera.